This is one of the most common questions or hesitations that we get from both employers and employees about drug testing.

Both sides of the issue are a little bit tricky, but the short answer is yes. Yes, an employer can require prescription medication disclosure, and, yes, employees must disclose medication if requested to do so by the employer. However, an employer can’t just require employees to disclose their prescriptions without having good reason to.

When is it appropriate to have a prescription medication disclosure in your workplace drug testing policy?

Unfortunately, there is no specific hard and fast rule for being allowed to mandate disclosure of prescription medications. The issue of privacy is very important in regards to protecting an employee’s rights. However, the issues of safety and liability beat out privacy in the case of safety-sensitive work. If there is a chance that the employee or others could be harmed due to impairment from a prescription drug, then employers are able to require prescription medication disclosure. As a general rule, employers must be able to prove that their request is job-related and consistent with business necessity.

Referencing current and past court cases related to prescription drug policies. The following seem to be good indicators that prescription drug policies should be enforced:

1. The employee is engaged in safety sensitive duties.
2. The drug in question may impact the employee’s ability to engage in safety-sensitive duties adversely.
3. The disclosure is only related to on-the-job drug use.
4. The information required to be disclosed is treated by the employer with the utmost discretion in order to safeguard the employee’s privacy.

If you have questions about getting started with drug testing for your own organization, please give us a call at 888-919-8378 or email us at mail@blueline-services.com. We’re more than happy to help!

The post Prescription Medication In The Workplace appeared first on Blueline.

Although, if we were to rewind time back to the early 1990’s, opioids likely wouldn’t be at the forefront of the public’s mind. And nobody would have anticipated the magnitude of the opioid crisis we face today.

We are currently standing a similar precipice with benzodiazepines—or at least many would argue this fact. A recent essay was published in the New England Journal of Medicine that highlighted this thought, titled “Our Other Prescription Drug Problem”.

What are benzodiazepines?

More commonly known by their brand names such as Xanax, Valium and Klonopin, benzodiazephines are tranquilizers that are used to treat anxiety and insomnia. They have a high potential to become extremely addictive and are especially dangerous when mixed with other drugs.

There has been massive growth in use and abuse of benzodiazephines or “benzos” in the U.S.. The number of deaths attributed to the drug has risen sevenfold over the past two decades, which isn’t surprising when you take into account that the number of benzodiazephine prescriptions have increased 67% to 13.5 million from 8.1 million in 1999. However, unlike opioid prescriptions, which peaked in 2012 and have decreased nearly 20 percent since then, benzo prescriptions are continuing to rise.

Like opioids, benzodiazepines increase a user’s feeling of stupor or drunkenness. Opioids and benzos are often taken together to increase an opioid high. In fact, in 2013, 23% of people who died of an opioid overdose also tested positive for benzos. This is extremely dangerous as benzodiazepines can increase an opioid’s power to slow breathing to a stop.And previous research has also suggested that patients who are prescribed benzos and opioids are four to ten times more likely to overdose than those who are prescribed opioids alone.

The amount of opioid users who also take benzodiazepines has doubled since 2001, which led the Food and Drug Administration (FDA) to issue a strong warning against co-prescribing the two drugs in 2016.

Preventing another epidemic

With the FDA strongly warning against co-prescribing and “black box warnings” being printed, it is hopefully that we can slow benzodiazepine abuse before it gets out of hand.

Other ways we can help prevent another epidemic from breaking out and slow our current prescription drug abuse problems include:

• Try using a safer alternatives for anxiety and insomnia first like behavioral interventions or long-term medications such as selective serotonin reuptake inhibitors.
• Raise awareness about the dangers of abusing prescription drugs and mixing prescriptions. Some individuals may not understand the serious consequences that can be involved with prescription drug abuse, help raise awareness by talking about this sometimes sensitive subject.
• If you are struggling, be open. If you have a problem with prescription abuse, tell your doctor and they can help you find a safe way to stop or limit your abuse. Abrupt withdrawal from prescription drugs can lead to serious side effects such as extreme anxiety, sleep disturbance, convulsions, and other serious problems.
• Address other problems before they lead to addictions. Leo Beletsky, a professor of law and health sciences at Northeastern University, spoke out about stopping the opioid crisis and other prescription abuse. “We have a lot of complex problems in this country. Without really addressing all of those physical, emotional, and mental health problems, just focusing on the [prescription drug] supply makes no sense — because people still have those problems.

The post America’s Next Big Drug Problem – Benzodiazepines appeared first on Blueline.